Pharmacologic mechanisms of crystal meth
- 17 June 2008
- journal article
- review article
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 178 (13), 1679-1682
- https://doi.org/10.1503/cmaj.071675
Abstract
Crystal meth is a form of the stimulant drug methamphetamine that, when smoked, can rapidly achieve high concentrations in the brain. Methamphetamine causes the release of the neurotransmitters dopamine, norepinephrine and serotonin and activates the cardiovascular and central nervous systems. The levels of dopamine are low in the brain of some drug users, but whether this represents neuronal loss is uncertain. The areas of the brain involved in methamphetamine addiction are unknown but probably include the dopamine-rich striatum and regions that interact with the striatum. There is no medication approved for the treatment of relapses of methamphetamine addiction; however, potential therapeutic agents targeted to dopamine and nondopamine (e.g., opioid) systems are in clinical testing.Keywords
This publication has 33 references indexed in Scilit:
- The epidemiology of methamphetamine use and harm in AustraliaDrug and Alcohol Review, 2008
- Why is parkinsonism not a feature of human methamphetamine users?Brain, 2004
- Monoamine transporters and psychostimulant drugsEuropean Journal of Pharmacology, 2003
- A New Anatomical Framework for Neuropsychiatric Disorders and Drug AbuseAmerican Journal of Psychiatry, 2003
- Pharmacokinetics of SLI381 (ADDERALL XR), an Extended-Release Formulation of AdderallJournal of the American Academy of Child & Adolescent Psychiatry, 2003
- Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled StudyAmerican Journal of Psychiatry, 2002
- Treatment of methamphetamine use disorders: an updateJournal of Substance Abuse Treatment, 2002
- Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependenceAddiction, 2001
- Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotoninSynapse, 2000
- Clinical effects of methamphetamine vapor inhalationLife Sciences, 1991